We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF
ARKG

213 hedge funds and large institutions have $528M invested in ARK Genomic Revolution ETF in 2025 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 39 increasing their positions, 69 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $482M → $528M (+$45.6M)

6% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 33

0% less funds holding

Funds holding: 214 → 213 (-1)

7% less call options, than puts

Call options by funds: $107M | Put options by funds: $116M

3.25% less ownership

Funds ownership: 53.18% → 49.93% (-3.2%)

43% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 69

Holders
213
Holders Change
-1
Holders Change %
-0.47%
% of All Funds
2.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
35
Increased
39
Reduced
69
Closed
33
Calls
$107M
Puts
$116M
Net Calls
-$8.28M
Net Calls Change
-$21M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$20.2M
2
UBS Group
UBS Group
Switzerland
+$8.64M
3
Citadel Advisors
Citadel Advisors
Florida
+$8.36M
4
Wells Fargo
Wells Fargo
California
+$3.37M
5
Two Sigma Investments
Two Sigma Investments
New York
+$2.74M

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$41.4M
2
Bank of America
Bank of America
North Carolina
-$16.8M
3
Morgan Stanley
Morgan Stanley
New York
-$5.23M
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$3.25M
5
SG Americas Securities
SG Americas Securities
New York
-$2.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
CA
226
Continuum Advisory
Idaho
– -$79.7K -3,837 Closed
HT
227
Headlands Technologies
Illinois
– -$44.6K -2,149 Closed
MCM
228
Manchester Capital Management
Vermont
– -$37.2K -1,791 Closed
HWM
229
Hemington Wealth Management
Virginia
– -$27K -1,310 Closed
CAWM
230
Capital A Wealth Management
Pennsylvania
– -$18.3K -880 Closed
MG
231
Mather Group
Illinois
– -$15.9K -767 Closed
QCG
232
Quadrant Capital Group
Ohio
– -$12.5K -600 Closed
CWC
233
Carolinas Wealth Consulting
North Carolina
– -$11.8K -568 Closed
MIM
234
Marshall Investment Management
Colorado
– -$8.6K -414 Closed
PFG
235
Putney Financial Group
California
– -$6.23K -300 Closed
MA
236
Montag & Associates
Georgia
– -$6.02K -290 Closed
DMIC
237
Dixon Mitchell Investment Counsel
British Columbia, Canada
– -$3.53K -170 Closed
NCM
238
Northwest Capital Management
Oregon
– -$3.09K -149 Closed
FAM
239
Flaharty Asset Management
Florida
– -$2.08K -100 Closed
EWA
240
EverSource Wealth Advisors
Alabama
– -$1.56K -75 Closed
SW
241
SVB Wealth
Massachusetts
– -$1.48K -71 Closed
RDFA
242
Ritter Daniher Financial Advisory
Ohio
– -$1.06K -51 Closed
TC
243
Truvestments Capital
Florida
– -$1.04K -50 Closed
CWM
244
CarsonAllaria Wealth Management
Illinois
– -$623 -30 Closed
WSFS
245
Wilmington Savings Fund Society
Delaware
– -$415 -20 Closed
CFD
246
Creative Financial Designs
Indiana
– -$272 -13 Closed
6 7 8 9
10

ARKG Hedge Fund Activity: Q2 2025 in Review

213 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2025, worth a combined $528M — up 9.5% from $482M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new ARKG positions and 33 closed out — a net gain of 2 holders — while 39 added to existing stakes and 69 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $20.2M. The largest seller was Citigroup, cutting an estimated $41.4M.

  • 213 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2025, down from 214 in Q1 2025.
  • Funds reported $528M of ARK Genomic Revolution ETF stock for Q2 2025, up 9.5% quarter-over-quarter.
  • 35 funds opened new ARK Genomic Revolution ETF positions in Q2 2025 and 33 closed out, a net change of +2 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q2 2025 was JP Morgan Chase, an estimated $20.2M added.
  • The largest ARK Genomic Revolution ETF seller in Q2 2025 was Citigroup, an estimated $41.4M sold.

Based on aggregated 13F filings for Q2 2025.